News | May 19, 2026
Lupin debuts in Dow Jones best-in-class indices for ESG performance
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Reinforcing commitment to ethical and sustainable growth
Ranks among the top 15% companies globally
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Subscribe To Our Newsletter & Stay Updated
